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The vigilant care of approximately 80 bottlenose dolphins (Tur-
siops truncatus) at the Navy Marine Mammal Program (MMP)
has led to this population’s higher annual survival rates, a 10-
year longer lifespan, and a higher proportion of dolphins liv-
ing 30–50 years compared to their wild counterparts (1, 2). The
MMP’s unprecedented biobank of tens of thousands of archived
clinical samples, collected as part of their care throughout the
dolphins’ lives for near a half-century, has been key to improv-
ing their health, as well as to discovering the unexpected. During
2007, our clinical research team was reviewing feeding and fasting
blood data from thousands of clinical blood samples. Surprisingly,
dolphins appeared to readily switch in and out of diabetes-like
states. Overnight fasted samples collected in the morning had
changes mimicking populations of people with diabetes, including
increased glucose, gamma-glutamyl transpeptidase, alkaline phos-
phatase; and decreased uric acid compared to samples collected
from the same dolphins later in the day (3). When dolphins were
fed a big meal of fish, they had an insulin-resistant response (sus-
tained postprandial hyperglycemia and hyperinsulinemia) (4).
When fed water with 10% dextrose, however, they had an insulin-
deficient response (sustained postprandial hyperglycemia with no
insulin) (5). Thus, dolphins could switch in and out of both type
2 and type 1 diabetes-like states.
These metabolic switches in dolphins were initially believed
to be limited to a natural, non-pathologic state. We now know,
however, that dolphins can develop metabolic syndrome, a dis-
ease also called prediabetes in humans, which affects one of
every three adults in the U.S. (4–10). Interestingly, there is com-
mon ground for co-evolved metabolism in dolphins and humans,
including shared large brain sizes with high demands for read-
ily available glucose and red blood cells that rapidly transport
glucose, a trait once thought to be unique to primates (11, 12).
Further, the carnivore hypothesis proposes that insulin resistance
in humans evolved to sustain adequate glucose levels when few
dietary carbohydrates were available during the Ice Age (13).
This evolutionary driver for insulin resistance coincides well with
the movement of dolphins from land to sea and their simi-
lar dietary shift from a high carbohydrate to high protein diet
(14).
This Frontiers in Endocrinology Research Topic, “Marine
Mammals as Out-of-the-box Models for Diabetes and Insulin
Resistance,” brings together novel science and sage thoughts from
multiple disciplines of experts who sought to expand our knowl-
edge of dolphin metabolism, metabolic disease, and their relevance
to human health. New science shared within includes identifi-
cation of case and reference dolphin populations for metabolic
syndrome, which open promising doors to discovering risk and
protective factors for this disease (5). Dr. Randall Wells et al. review
the life history of free-ranging dolphins living in Sarasota Bay,
FL, USA to propose potential means to treat and prevent insulin
resistance, including diversifying fish species eaten, and grazing or
snacking throughout the day and night instead of eating fewer,
large meals (15).
Dr. Benjamin Neely et al. dive deeper to assess the potential
risk of insulin resistance in dolphins with lower levels of high-
weight adiponectin (5, 16). Previous studies in mice and humans
have demonstrated the insulin-sensitizing effect of adiponectin
and its decreasing beneficial impact in the face of iron overload.
Dr. Neeley et al.’s discovery of disrupted associations between
adiponectin and glucagon in dolphins with high insulin and iron
overload, paired with high sequence similarity of dolphin and
human adiponectin, continue to support increasing high-weight
adiponectin as a potential therapeutic target for people and other
animals with these diseases (16). Dr. Kirsten Eberle et al. use their
newly developed, dolphin-specific immunoassays to characterize
inflammation present in a 46-year old dolphin with metabolic
syndrome and iron overload compared to a dolphin without these
diseases (17). Parallels in chronic inflammation among people
and dolphins with metabolic syndrome are reported, enhanc-
ing the emerging story of chronic inflammation and metabolic
perturbations.
Dr. Thomas Schermerhorn describes how the same meta-
bolic response can be normal in carnivores (cats and dolphins)
but cause diabetes in humans, providing potential clues as to
how insulin resistance may be better controlled in humans (18).
A review of northern elephant seal metabolism by Dr. Dorian
Houser et al. showcases an extreme version of fasting metabolism
in mammals, including their amazing ability to fast for months
and sustain a diabetes-like state without developing ketoacido-
sis (19). Understanding how northern elephant seals can protect
themselves against this deadly metabolic state may lead to new
approaches in humans with type 1 diabetes. Dr. Sam Ridgway
demonstrates dolphins’ lack of an increased respiratory quotient
(i.e., oxidative response) while metabolizing glucose, a potential
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trick that may protect dolphins against the direct, damaging effects
of hyperglycemia (20).
This Research Topic also has two articles proposing dolphins,
with large volumes of forcefully exhaled breaths from deep lung, as
ideal for discovering novel breath-based indicators of metabolism
(20, 21). Dolphins have evolved to move large amounts of oxy-
gen from the air into their blood with extreme efficiency using
double capillary layers in the lungs. In turn, this trait enables
blood-based metabolites to cross over to their breath, providing a
gift of clean, compound-rich exhaled breath condensate prime for
biomarker discovery. These biomarkers may one day enable non-
invasive screening and monitoring of metabolic health in humans
and wild cetaceans (22).
The global pandemic of diabetes demands big, game-changing
discoveries. Outside traditional scientific laboratories are millions
of years of trials that have led to an estimated 8.7 million eukary-
otic species on Earth, most of which are in the ocean (23). Today,
mechanical engineers are looking to butterflies, bees, and cheetahs
for novel ideas to advance machines. Similarly, we can look increas-
ingly to nature for new approaches to cure diseases. By doing so,
there comes the benefit of calling upon human health experts to
improve animal and environmental health, too. This is the core
of the global One Health movement. By taking exceptional care
of one together, we can help many. Earth’s 8.7 million species,
including the bottlenose dolphin, means 8.7 million chances to
make big, positive changes, including better preventing, manag-
ing, treating, and curing diabetes. As we move forward, may we
actively engage in applying One Health to work together – as physi-
cians, veterinarians, scientists, and biologists – to improve health
for all.
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